The effects of serotonin on the differentiation of neurons producing vasoactive intestinal polypeptide in the suprachiasmatic nucleus of the rat

Immunocytochemical evidence for different patterns in daily rhythms of VIP and AVP peptides in the suprachiasmatic nucleus of diurnal Funambulus palmarum

The suprachiasmatic nucleus (SCN) is the principal pacemaker that coordinates circadian rhythmicity in mammals. The studies on understanding the circadian system in diurnal rodents are limited. In this study, we have used the 3 striped South Indian Palm Squirrel (Funambulus palmarum). The locomotor activity showed a diurnal pattern of activity in LD 12:12, constant darkness (DD) and light (LL) conditions with circadian periods (τ) of 24.19 ± 0.1, 24.11 ± 0.03 and 24.92 ± 0.35 h respectively. Anatomical study of the brain revealed that this animal had short, thick and stout optic nerves with SCN elliptical in shape with a higher neuronal population as distinct from nocturnal rodents. Since the neuropeptides, vasoactive intestinal polypeptide (VIP) and arginine vasopressin (AVP) play important roles in photic entrainment and relay of information respectively in nocturnal rodents, we studied the distribution and daily rhythms of VIP-ir and AVP-ir in squirrel SCN. The VIP-ir and AVP-ir cells in the SCN showed a ventrolateral and dorsomedial distribution with daily rhythmicity in their levels. The peak time of VIP-ir rhythm was found ahead of AVP-ir. The VIP-ir levels were higher for longer duration than AVP-ir levels. The maximum and minimum VIP-ir levels were at ZT-6 and ZT-0 respectively and AVP-ir levels at ZT-12 and ZT-0 respectively. Thus, VIP and AVP maximum and minimum levels appeared 6 and 12h apart respectively in squirrel, though 12 and 8h apart in rat. These findings in the present report could be a step towards underpinning the mechanisms regulating diurnality.

Postulated vasoactive neuropeptide autoimmunity in fatigue-related conditions: a brief review and hypothesis

Disorders such as chronic fatigue syndrome (CFS) and gulf war syndrome (GWS) are characterised by prolonged fatigue and a range of debilitating symptoms of pain, intellectual and emotional impairment, chemical sensitivities and immunological dysfunction. Sudden infant death syndrome (SIDS) surprisingly may have certain features in common with these conditions. Post-infection sequelae may be possible contributing factors although ongoing infection is unproven. Immunological aberration may prove to be associated with certain vasoactive neuropeptides (VN) in the context of molecular mimicry, inappropriate immunological memory and autoimmunity. Adenylate cyclase-activating VNs including pituitary adenylate cyclase-activating polypeptide (PACAP), vasoactive intestinal peptide (VIP) and calcitonin gene-related peptide (CGRP) act as hormones, neurotransmitters, neuroregulators, immune modulators and neurotrophic substances. They and their receptors are potentially immunogenic. VNs are widely distributed in the body particularly in the central and peripheral nervous systems and have been identified in the gut, adrenal gland, blood cells, reproductive system, lung, heart and other tissues. They have a vital role in maintaining cardio-respiratory function, thermoregulation, memory, concentration and executive functions such as emotional responses including social cues and appropriate behaviour. They are co-transmitters for a number of neurotransmitters including acetylcholine and gaseous transmitters, are potent immune regulators with primarily anti-inflammatory activity, and have a significant role in protection of the nervous system against toxic assault as well as being important in the maintenance of homeostasis. This paper describes a biologically plausible mechanism for the development of certain fatigue-related syndromes based on loss of immunological tolerance to these VNs or their receptors following infection, other events or de novo resulting in significant pathophysiology possibly mediated via CpG fragments and heat shock (stress) proteins. These conditions extend the public health context of autoimmunity and VN dysregulation and have implications for military medicine where radiological, biological and chemical agents may have a role in pathogenesis. Possible treatment and prevention options are considered.

Therapeutic and preventive interventions for postulated vasoactive neuropeptide autoimmune fatigue-related disorders

Major advances have been made in understanding the relatively novel group of vasoactive (vasodilatory) neuropeptides (VNs) in humans. VNs comprise a novel but expanding group of substances having immunoregulation, inflammation modulation, neurotransmitter, neurotrophic, hormonal and metabolic functions. These substances may control gene expression for mRNA for themselves and their receptors. They have complex relationships with gaseous and other neurotransmitters and xenobiotic substances. Theoretical arguments have implicated these substances in autoimmune phenomena resulting in fatigue-related conditions such as chronic fatigue syndrome (CFS), sudden infant death syndrome (SIDS), fibromyalgia (FM) and Gulf War syndrome (GWS) but remain unproven. As well as possibly spontaneous onset, the precipitating causes of VN autoimmune dysfunction are likely to be a combination of genetic predisposition, infection and xenobiotic substances. Therapeutic and preventive possibilities for postulated VN autoimmune conditions will be influenced by the complex patholophysiology underpinning them. Some speculative possibilities are VN substitution/replacement, preservation of biological effect, epigenetic DNA modifications, plasma exchange, anti-cholinesterases, e.g., pyridostigmine, corticosteroids and other drug treatments, thymectomy, intravenous immunoglobulin and anti-idiotype antibodies, and CpG/DNA vaccines. Prevention and treatment of possible VN autoimmune fatigue-related disorders may prove to be important areas for future research and development.